328 IF3-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organic acids and derivatives | 19 | 7.9 | 2.40× | q = 4.2e-4 | |
| Nucleosides, nucleotides, and analogues | 22 | 14.2 | 1.55× | q = 0.03 | |
| Homogeneous non-metal compounds | 14 | 11.0 | 1.27× | q = 0.39 | |
| Homogeneous metal compounds | 26 | 25.2 | 1.03× | q = 0.93 | |
| Organic oxygen compounds | 8 | 10.2 | 0.78× | q = 0.68 | |
| Organoheterocyclic compounds | 2 | 7.9 | 0.25× | q = 0.03 | |
| Lipids and lipid-like molecules | 0 | 5.7 | 0 | q = 0.01 | |
| Organosulfur compounds | 1 | 1.1 | 0.95× | not tested | |
| Organic nitrogen compounds | 1 | 1.6 | 0.61× | not tested | |
| Benzenoids | 2 | 3.8 | 0.53× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04328 | S3P | Shikimate-3-Phosphate | 66 |
| DB03397 | UD1 | Uridine-Diphosphate-N-Acetylglucosamine | 60 |
| DB04539 | GPJ | Glyphosate | 33 |
| DB01733 | 0V5 | L-Phospholactate | 32 |
| DB04174 | UDA | 3'-1-carboxy-1-phosphonooxy-ethoxy-uridine-diphosphate-N-acetylglucosamine | 32 |
| DB01819 | PEP | Phosphoenolpyruvate | 14 |
| DB00171 | ATP | ATP | 11 |
| DB01861 | UPG | Uridine diphosphate glucose | 10 |
| DB03435 | UDP | Uridine-5'-Diphosphate | 10 |
| DB01879 | TAV | (S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid | 8 |
| DB02995 | HAI | Cyclohexylammonium Ion | 8 |
| DB00131 | AMP | Adenosine phosphate | 7 |
| DB03345 | BME | Mercaptoethanol | 7 |
| DB00125 | ARG | Arginine | 4 |
| DB03116 | SKP | 5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate | 4 |
| DB01694 | TAR | D-tartaric acid | 3 |
| DB00640 | ADN | Adenosine | 2 |
| DB02196 | UD2 | Uridine-Diphosphate-N-Acetylgalactosamine | 2 |
| DB04005 | UTP | Uridine 5'-triphosphate | 2 |
| DB00142 | — | Glutamic acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 105 |
| S3P | SHIKIMATE-3-PHOSPHATE | 85 |
| EPU | URIDINE-DIPHOSPHATE-2(N-ACETYLGLUCOSAMINYL) BUTYRIC ACID | 78 |
| UD1 | URIDINE-DIPHOSPHATE-N-ACETYLGLUCOSAMINE | 60 |
| EPZ | (2R)-2-{[(2R,3R,4R,5S,6R)-3-(acetylamino)-2-{[(S)-{[(R)-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoic acid | 58 |
| GPJ | GLYPHOSATE | 55 |
| CL | CHLORIDE ION | 50 |
| MGmetal | MAGNESIUM ION | 36 |
| 0V5 | (2R)-2-(phosphonooxy)propanoic acid | 32 |
| UDA | 3'-1-CARBOXY-1-PHOSPHONOOXY-ETHOXY-URIDINE-DIPHOSPHATE-N-ACETYLGLUCOSAMINE | 32 |
| FFQ | [(1R)-1-hydroxypropyl]phosphonic acid | 30 |
| NAmetal | SODIUM ION | 26 |
| PO3 | PHOSPHITE ION | 24 |
| Kmetal | POTASSIUM ION | 17 |
| SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX-1-ENE-1-CARBOXYLIC ACID | 16 |
| PEP | PHOSPHOENOLPYRUVATE | 14 |
| CAmetal | CALCIUM ION | 10 |
| UDP | URIDINE-5'-DIPHOSPHATE | 10 |
| HAI | CYCLOHEXYLAMMONIUM ION | 9 |
| UPG | URIDINE-5'-DIPHOSPHATE-GLUCOSE | 9 |